Eastside Research Associates | Redmond, WA
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
This study will investigate the efficacy and safety of once daily oral orforglipron in adult participants with obesity or overweight with weight-related comorbidities.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Have a BMI
≥30.0 kilogram/square meter (kg/m²),
≥27.0 kg/m² and presence of at least 1 of the following weight-related comorbidities (treated or untreated) at screening:
Have a history of at least 1 self-reported unsuccessful dietary effort to lose body weight.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
3,000 participants in 4 patient groups, including a placebo group
Loading...
Central trial contact
There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal